WuXi PharmaTech Statement on Recent News Report

SHANGHAI, Jan. 5, 2015 /PRNewswire/ -- WuXi PharmaTech stated today that a recent news report regarding purported FDA communication with a company named Novacyl Wuxi Pharmaceutical does not relate to WuXi PharmaTech.

Ron Aldridge 
Director of Investor Relations 
WuXi PharmaTech 
+1 201-585-2048 
+1 952-594-0148 (U.S.)

SOURCE WuXi PharmaTech

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED